Skip to main content
. 2018 Nov;80(4):571–582. doi: 10.18999/nagjms.80.4.571

Fig. 2.

Fig. 2

Number of patients with each laboratory prognostic score (LPS) (primary graph, presented as bars) and 30-day survival (secondary graph, presented as a line)

(A) Investigation group (n=761), (B) Validation group (n=547).